Prestige Consumer Healthcare (PBH) FY2024 results: revenue $1.1 billion, down 0.2% on the year

Prestige Consumer Healthcare Inc. (PBH) reported revenue of $1.1 billion for fiscal 2024, the year ended 31 March 2024, down 0.2% on the year before. Net income was $209 million, and diluted earnings per share $4.17. The figures are the company's own, from the 10-K it filed with the SEC on 15 May 2024.

Revenue

$1.1 billion

-0.2% on the year

FY2017FY2024

Operating margin

30.4%

-2.0% a year earlier

FY2017FY2024

Net income

$209 million

FY2017FY2024

Diluted EPS

$4.17

FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ million	FY2024	FY2023	FY2022	On the year
Revenue	1,125	1,128	1,087	-0.2%
Cost of revenue	501	502	466	-0.3%
Gross profit	624	625	621	-0.1%
Gross margin	55.5%	55.4%	57.1%
Operating income	342	-22.4	330
Operating margin	30.4%	-2.0%	30.4%
Interest expense	5.2	4.4	64.3	+18.2%
Pre-tax income	276	-93.9	262
Income tax	66.7	-11.6	57.1
Effective tax rate	24.2%	n/a	21.7%
Net income	209	-82.3	205
Net margin	18.6%	-7.3%	18.9%
Diluted EPS	$4.17	-$1.65	$4.04

$ million except per share.

Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ million	FY2024	FY2023	FY2022	On the year
Operating cash flow	249	230	260	+8.4%
Capital expenditure	9.6	7.8	9.6	+22.7%
Free cash flow	239	222	250	+7.9%
Free cash flow margin	21.3%	19.7%	23.0%
Cash from investing	-20.1	-11.6	-257
Cash from financing	-241	-186	-7.6
Depreciation and amortisation	30.7	32.6	32.1	-6.0%
Share-based compensation	14.0	12.4	9.0	+12.9%
Buybacks	25.0	50.0	0.0	-50.0%
Diluted shares, weighted	50m	50m	51m	+0.6%

Balance sheet

$ million	FY2024	FY2023	FY2022	On the year
Shareholders' equity	1,655	1,447	1,578	+14.4%
Debt	1,126	1,346	1,477	-16.3%
Operating lease liabilities	7.5	9.9	16.1	-23.8%
Finance lease liabilities	0.2	1.7	4.5	-89.7%
Other liabilities	530	549	596	-3.5%
Total liabilities and equity	3,318	3,354	3,671	-1.1%
Fixed assets	76.5	70.4	71.3	+8.7%
Goodwill	528	528	579	+0.0%
Intangible assets	2,321	2,342	2,697	-0.9%
Cash and equivalents	46.5	58.5	27.2	-20.6%
Receivables	177	167	139	+5.8%
Inventory	139	162	120	-14.4%
Other assets	31.6	26.2	36.9	+20.5%
Total assets	3,318	3,354	3,671	-1.1%

10-K for the year ended 31 March 2024, filed 15 May 2024: the filing.